VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank29
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P29
Within normal range
vs 5Y Ago
-3.7x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-69.51%
202444.29%
2023-24.05%
2022-166.42%
202110.22%
202018.66%
2019-72.94%
2018-38.55%
201742.59%
2016-163.39%